Myomo (MYO) Total Debt Growth (1y) (2025)
Myomo (MYO) Total Debt Growth (1y) (2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.52 Bn | 176.22 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 108.61 Bn | 99.39 Bn | 6.41 Bn | -1.95% |
| 4 | Boston Scientific | 68.35 Bn | 66.90 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 48.53 Bn | 44.86 Bn | 1.29 Bn | 0.12% |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | -5.76% |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | -2.49% |
| 9 | Koninklijke Philips | 25.49 Bn | 22.36 Bn | 2.07 Bn | 19.06% |
| 10 | Myomo | 43.85 Mn | 24.89 Mn | - | 24.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24.36% |